2018 Apr 18: New video posted. Father's Day Walk/Run coming soon. Join our team. Click on the Donate button above.

Treatments

An Optimist’s Guide to Your Prostate

May 21, 2018

This is a comprehensive article from Esquire about most aspects of prostate cancer. Read the article.

Read the article or watch the video →

Expert Discusses Radiation Techniques, Genomic Testing in Prostate Cancer

May 20, 2018

A discussion of radiation techniques and genomic testing in prostate cancer. Read the article here.

Read the article or watch the video →

Finasteride does not increase risk of prostate cancer death

May 20, 2018

The landmark Prostate Cancer Prevention Trial has delivered a final verdict. Finasteride, a common hormone-blocking drug, reduces mens’ risk of getting prostate cancer without increasing their risk of dying from the disease. Initial study findings suggested there may be a link between use of the drug and a more lethal form of prostate cancer, but […]

Read the article or watch the video →

Active surveillance in men with Gleason 3 + 4 = 7 prostate cancer at diagnosis

May 20, 2018

A critical question for men with favorable intermediate-risk prostate cancer (based primarily on a Gleason score of 3 + 4 = 7) can often be, “How safe would it be for me to go on active surveillance for a while after initial diagnosis?” Read the article here.

Read the article or watch the video →

Video: “How clinical trials have changed prostate cancer care”

April 13, 2018

March 2018 Awareness Night How clinical trials have changed prostate cancer care   Dr. Andrew Loblaw BSc MD MSc FRCPC CIP Clinician Scientist , Ontario Association of Radiation OncologyStaff Radiation Oncologist & Clinician Scientist, Sunnybrook Health Sciences Centre Scientist, Sunnybrook Research Institute Fellow, American Society of Clinical Oncology  (ASCO) Co-Chair, GU group for Cancer Care […]

Read the article or watch the video →

When can active surveillance be less active?

April 2, 2018

A substantial proportion of men with low-risk prostate cancer can safely be followed with a de-intensified active surveillance protocol. Read the article here.

Read the article or watch the video →

No Benefit for Aggressive Therapy in Metastatic Prostate Cancer

April 2, 2018

For men with metastatic prostate cancer there is no survival advantage for aggressive therapy over conservative androgen deprivation therapy only, according to a study. Read the article here.

Read the article or watch the video →

Biopsy-to-RP Delay May Up Prostate Cancer Recurrence Risk

April 2, 2018

A greater than 90-day delay from prostate biopsy to radical prostatectomy for localized prostate cancer may increase the risk of biochemical recurrence of disease, according to study findings. Read the article here.

Read the article or watch the video →

A mix of treatments may extend life for men with aggressive prostate cancer

April 2, 2018

A new study shows that a mix of different treatments, or a “multimodal” approach to prostate cancer therapy, lengthens survival in men who have this diagnosis. Read the article here.

Read the article or watch the video →

Finasteride can reduce prostate cancer risk long term

April 2, 2018

A drug used to treat enlarged prostate or hair loss in men has been shown to have a long-term protective effect against prostate cancer. Read the article here.

Read the article or watch the video →